The company (formerly Salute Mission Critical) announced the acquisition last week. Terms were not shared. Founded in 2018, ADCC is described as a provider of AI-driven data center training and ...

Trastuzumab, tested only as a single agent, has been shown to achieve 7% response in heavily pretreated patients with AOC with 3+ and 2+ HER2 immunostaining by immunohistochemistry (IHC).

Muc-1 α-gal epitope (HyperAcute®) NCT00569387 Active, not recruiting II Muc-1 α-gal epitope (HyperAcute®) NCT00614601 Active, not recruiting II Muc-1 α-gal epitope (HyperAcute®) NCT01072981 ...

NEW YORK – Oncologists used Reveal Genomics' predictive assay, HER2DX, to alter neoadjuvant and adjuvant ... 57 percent had another anti-HER2 agent added to Genentech's Herceptin (trastuzumab), such ...

Protein concentrations were quantified using a bicinchoninic acid assay (BCA) (Pierce Biotechnology ... a key animal model for the translation of immunotherapies. The study of ADCC in rodent syngeneic ...

TORONTO, ON / ACCESS Newswire / March 11, 2025 / Magna Terra Minerals Inc. (the "Company" or "Magna Terra") (TSXV:MTT) today announces that it has filed an early warning report in respect of Gold ...

It has been illustrated in Figure 6. Cytotoxicity of synthesized NPs was assessed by using two triple-negative breast cancer cell lines: SUM-149 and MDA-MB 231, through cell proliferation assay (MTT ...